These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 12716541)

  • 1. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
    Shapiro MF; Morton SC; McCaffrey DF; Senterfitt JW; Fleishman JA; Perlman JF; Athey LA; Keesey JW; Goldman DP; Berry SH; Bozzette SA
    JAMA; 1999 Jun 23-30; 281(24):2305-15. PubMed ID: 10386555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons?
    Sohler NL; Li X; Cunningham CO
    AIDS Patient Care STDS; 2009 Sep; 23(9):775-83. PubMed ID: 19663745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.
    Cunningham CO; Sohler NL; Cooperman NA; Berg KM; Litwin AH; Arnsten JH
    Subst Use Misuse; 2011; 46(2-3):218-32. PubMed ID: 21303242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors.
    Ruiz Perez I; Rodriguez Baño J; Lopez Ruz MA; del Arco Jimenez A; Causse Prados M; Pasquau Liaño J; Martin Rico P; de la Torre Lima J; Prada Pardal JL; Lopez Gomez M; Muñoz N; Morales D; Marcos M
    Qual Life Res; 2005 Jun; 14(5):1301-10. PubMed ID: 16047505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review.
    Nicastri E; Leone S; Angeletti C; Palmisano L; Sarmati L; Chiesi A; Geraci A; Vella S; Narciso P; Corpolongo A; Andreoni M
    J Antimicrob Chemother; 2007 Oct; 60(4):724-32. PubMed ID: 17715125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to use of free antiretroviral therapy in injection drug users.
    Strathdee SA; Palepu A; Cornelisse PG; Yip B; O'Shaughnessy MV; Montaner JS; Schechter MT; Hogg RS
    JAMA; 1998 Aug; 280(6):547-9. PubMed ID: 9707146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.
    Celentano DD; Galai N; Sethi AK; Shah NG; Strathdee SA; Vlahov D; Gallant JE
    AIDS; 2001 Sep; 15(13):1707-15. PubMed ID: 11546947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.
    Cunningham WE; Markson LE; Andersen RM; Crystal SH; Fleishman JA; Golin C; Gifford A; Liu HH; Nakazono TT; Morton S; Bozzette SA; Shapiro MF; Wenger NS
    J Acquir Immune Defic Syndr; 2000 Oct; 25(2):115-23. PubMed ID: 11103041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health services utilization according to gender in a cohort of intravenous drug users infected with HIV].
    García de la Hera M; Ruiz I; Pérez-Hoyos S; Hernández Aguado I
    Med Clin (Barc); 2003 Apr; 120(13):489-93. PubMed ID: 12716541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.
    Lert F; Kazatchkine MD
    Int J Drug Policy; 2007 Aug; 18(4):255-61. PubMed ID: 17689373
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.